Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
CNEY Wins a Large Activated Carbon Order 2023-03-20 20:30
I-Mab to Report Full Year 2022 Financial Results and Provide Corporate Update on March 31, 2023 2023-03-20 20:00
RVAC Medicines announces research collaboration with University of Pennsylvania mRNA Vaccine Pioneer 2023-03-17 21:00
Hanmi Pharmaceutical's Combination Drug for Dyslipidemia Treatment, 'Rosuzet': Confirmed Non-inferiority Efficacy and Safety Compared to Monotherapy in 'The Lancet' & 'European Heart Journal' 2023-03-17 21:00
Samsung Biologics announces construction of Plant 5 to commence Bio Campus II capacity expansion 2023-03-17 19:25
SYMBYX announces promising Sydney Adventist Hospital clinical trial results for Parkinson's using the SYMBYX Neuro - a new light therapy wellness helmet 2023-03-17 18:30
GCCL Develops PBMC Resource Management System 2023-03-17 09:26
Nav1.7 Selective Inhibitor OLP-1002 Shows Strong Efficacy and Long Therapeutic Duration according to Interim Findings from a Phase 2a Study in OA Patients 2023-03-16 21:00
FDA Approves Expanded Indication for Telix's Illuccix® to Include Patient Selection for PSMA-Directed Radioligand Therapy 2023-03-16 20:28
Akeso Reported 2022 Annual Results 2023-03-16 08:26
Lunit to Present 5 Abstracts at the 2023 AACR Annual Meeting 2023-03-15 21:14
Bridge Biotherapeutics to Present Updated Preclinical Data of BBT-207 at the AACR 2023 Annual Meeting 2023-03-15 21:00
HanAll Biopharma Opens Applications for the 2023 Pharmaceutical Industry Fellowship Program 2023-03-15 19:00
Jacobio Pharma to Present Data of Three Preclinical Studies at the 2023 AACR Annual Meeting 2023-03-15 10:45
Ascentage Pharma to Present Latest Results from Three Preclinical Studies at 2023 American Association for Cancer Research Annual Meeting 2023-03-15 07:59
Mabwell Launched First in human Clinical Trial of Its Iron Homeostasis Regulating Macromolecular Drug 9MW3011 2023-03-14 23:42
Simcere Zaiming Announces Clinical Collaboration to Evaluate SIM0235, a TNFR2 Monoclonal Antibody, in Combination with KEYTRUDA® (pembrolizumab) in a Phase 1 Trial in Advanced Solid Tumors and Cutaneous T-cell Lymphoma 2023-03-14 20:00
Patient Enrollment Completed for Phase III Clinical Trial of Akeso's Cadonilimab in Treatment of Gastric Cancer 2023-03-14 17:01
DeepCare debuts at IDS Cologne 2023 2023-03-14 16:00
Austco Augments Industry-leading Nurse Call and Healthcare Communications Solutions with 4D Imaging Radar Fall Detection by Vayyar 2023-03-13 22:00
1 89 90 91 92 93 432